Global ADHD Drugs market to grow at a CAGR of 5.33 percent over the period 2013-2018

1
Global ADHD Drugs Market 2014-2018
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast 2018
Published Date Oct 2014
2
Report Description
About ADHD ADHD is a psychiatric disorder, which
is mostly found in children. However, adults have
also been reported to be diagnosed with ADHD. The
patients with ADHD suffer from several problems
including hyperactivity, impulsiveness, and lack
of focus and concentration. The causes of ADHD
are not known. It is believed to be linked with
genetic and environmental causes. However, it has
been reported to be related with the decrease in
the extraneuronal levels of norepinephrine and
dopamine. In addition, the patients have an
abnormality in the brain structure. It is more
prevalent in boys than girls. The management of
ADHD is done by counseling, medications, and
lifestyle changes. Global ADHD Drugs market to
grow at a CAGR of 5.33 percent over the period
2013-2018. Get Complete Report At
http//www.bigmarketresearch.com/global-adhd-drugs
-2014-2018-market Covered in this Report This
report covers the present scenario and the growth
prospects of the Global ADHD Drugs market for the
period 2014-2018. To calculate the market size,
the report considers the revenue generated from
the sales of various therapies used in the
treatment of ADHD, which include
3
Report Description
Stimulants Non-stimulants The Global ADHD
Drugs Market 2014-2018, has been prepared based
on an in-depth market analysis with inputs from
industry experts. The report covers the Americas,
and the EMEA and APAC regions it also covers the
Global ADHD Drugs market landscape and its growth
prospects in the coming years. The report also
includes a discussion of the key vendors
operating in this market. Key Regions Americas
APAC EMEA Enquire About this report
http//www.bigmarketresearch.com/report-enquiry/14
4024 Key Vendors Eli Lilly and Janssen
Novartis Shire
4
Report Description
Other Prominent Vendors Actavis Alcobra
Amarantus Boehringer Ingelheim Concordia
Curemark GlaxoSmithKline Hisamitsu Impax
Intellipharmaceutics Mylan Neurovance
Noven Par Pharmaceuticals Sanofi Shionogi
Sunovion Teva Tris Pharma
5
Report Description
Market Driver Presence of Unmet Need For a
full, detailed list, view our report Market
Challenge Unknown Etiology For a full,
detailed list, view our report Market Trend
Increase in Awareness For a full, detailed
list, view our report Key Questions Answered in
this Report What will the market size be in
2018 and what will the growth rate be? What are
the key market trends? What is driving this
market? What are the challenges to market
growth? Who are the key vendors in this market
space? What are the market opportunities and
threats faced by the key vendors? What are the
strengths and weaknesses of the key vendors?
6
Table of Contents
01 Executive Summary 02 List of Abbreviations 03
Scope of the Report 04 Market Research
Methodology 05. Market Research Methodology 06.
Introduction 07. Market Landscape 08. Market
Segmentation by Product Type 09. Market
Segmentation by Route of Administration 10.
Market Segmentation by Dosage Form 11.
Geographical Segmentation 12. Key Leading
Countries 13. Rate of Incidence and
Prevalence 14. Buying Criteria 15. Market Growth
Drivers 16. Drivers and their Impact 17. Market
Challenges 18. Impact of Drivers and
Challenges 19. Market Trends 20. Trends and their
Impact
7
FOR MORE DETAILS
Visit us at
http//www.bigmarketresearch.com/global-adhd-drugs
-2014-2018-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone]E-MAIL
help_at_bigmarketresearch.com